We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomonitoring Device Improves Detection of Toxic Metals

By Labmedica staff writers
Posted on 25 Feb 2008
A new rapid, portable, and inexpensive detection system has been developed that identifies personal exposures to toxic lead and other dangerous heavy metals. More...
The device can provide an accurate blood sample measurement from a simple finger prick, which is particularly important when sampling children.

Accumulation of lead in children can harm the developing brain, causing reduced IQ, learning disabilities, and behavioral problems, among other things. The U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) report that about 310,000 U.S. children ages one to five have high levels of lead in their blood. Recent studies also indicate a link between lead exposure and a decline in mental ability many years later. In addition, large numbers of industrial workers are routinely exposed to toxic heavy metals such as cadmium, lead, and mercury, which are known to induce various diseases.

The new analyzer system accurately detects lead and other toxic metals in urine and saliva as well as in blood. The device may be as much as 10 times less expensive than current plasma mass spectrometry (MS) systems, which require samples to be returned to the lab for time-consuming and expensive analysis The new system provides an excellent method of monitoring toxic metal exposures in high-risk populations, such as industrial workers, children, and people living in polluted areas.

Two classes of sensors are used for detecting lead and other heavy metals. The first is based on a flow injection system using a mercury-film electrode to analyze metals in blood, urine, or saliva samples. The second is based on a mercury-free approach of nanostructure materials. It either uses self-assembled monolayers on mesoporous supports (SAMMS) technology--or functionalized magnetic nanoparticles that provide excellent detection sensitivity at a ppb level.

A product of The U.S. Department of Energy's (DOE) Pacific Northwest National Laboratory (PNNL; Richland, WA, USA), the monitoring device is a bit larger than a lunchbox, and is suitable for use in the field. It has plug-and-play features that allow different sensors to be easily exchanged to detect a variety of heavy metal toxins. The entire system is battery-operated, and requires about 50% more power than a typical laptop computer.

Battelle, which operates PNNL for the DOE, filed a patent application in December 2007 for the improved sensor technology used in this next-generation biomonitoring device.


Related Links:
U.S. Centers for Disease Control and Prevention
U.S. Department of Energy's Pacific Northwest National Laboratory
Battelle

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.